Variant report
Variant | esv3391328 |
---|---|
Chromosome Location | chr14:66809399-66811947 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs114611421 | chr14:66809414-66809415 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542918542 | chr14:66809486-66809487 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs145031999 | chr14:66809489-66809490 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557202191 | chr14:66809547-66809548 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541056941 | chr14:66809563-66809564 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192418279 | chr14:66809663-66809664 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs570613927 | chr14:66809687-66809688 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373335593 | chr14:66809692-66809693 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs184608898 | chr14:66809698-66809699 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs559406612 | chr14:66809713-66809714 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552835744 | chr14:66809742-66809743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374658028 | chr14:66809766-66809767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs36091391 | chr14:66809767-66809768 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572881847 | chr14:66809768-66809769 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs28521841 | chr14:66809799-66809800 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs555313629 | chr14:66809816-66809817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs72722483 | chr14:66809834-66809835 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs543664762 | chr14:66809960-66809961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563541748 | chr14:66809998-66809999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532613824 | chr14:66810046-66810047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531052947 | chr14:66810070-66810071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200336966 | chr14:66810085-66810086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10143013 | chr14:66810089-66810090 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs559624933 | chr14:66810117-66810118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs67227265 | chr14:66810138-66810139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563805476 | chr14:66810173-66810174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs56003693 | chr14:66810182-66810183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530379309 | chr14:66810184-66810185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs374978187 | chr14:66810280-66810281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs370768003 | chr14:66810281-66810282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs57525517 | chr14:66810294-66810295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs28520346 | chr14:66810331-66810332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs368934821 | chr14:66810334-66810335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs529285895 | chr14:66810342-66810343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs373945414 | chr14:66810343-66810344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10143446 | chr14:66810344-66810345 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10143448 | chr14:66810346-66810347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs553766532 | chr14:66810348-66810349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs141926756 | chr14:66810350-66810351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565424580 | chr14:66810355-66810356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550943701 | chr14:66810398-66810399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs35533940 | chr14:66810399-66810400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188238317 | chr14:66810406-66810407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs35350940 | chr14:66810410-66810411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs116511110 | chr14:66810449-66810450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192680245 | chr14:66810505-66810506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs371016038 | chr14:66810601-66810602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs566464274 | chr14:66810618-66810619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371777214 | chr14:66810645-66810646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs374551513 | chr14:66810646-66810647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Breast cancer | 22032731 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17603634 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 17133270 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 17440070 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:66797800-66811800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr14:66808800-66809400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr14:66809000-66809600 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr14:66809200-66809600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr14:66809400-66809600 | Enhancers | Hela-S3 | cervix |
6 | chr14:66809400-66809800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr14:66809600-66811000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr14:66811000-66812800 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr14:66811800-66814000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |